Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Taisho Pharma : New Agent for Osteoporosis Approved in Japan “Bonviva® IV Injection”
Taisho Pharma : New Agent for Osteoporosis Approved in Japan “Bonviva® IV Injection”
Taisho Pharma : New Agent for Osteoporosis Approved in Japan “Bonviva® IV Injection”
Submitted by
moderatorj
on June 29, 2013 - 12:55pm
Source:
4 Traders
News Tags:
Tashio Pharma
osteoporosis
Japan
Bonviva
regulatory
Headline:
Taisho Pharma : New Agent for Osteoporosis Approved in Japan “Bonviva® IV Injection”
Do Not Allow Advertisers to Use My Personal information